Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,497 public trials 2,844 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Active, not recruiting

Safety Study of Gene Modified Donor T-cells Following Partially Mismatched Stem Cell Transplant

NCT01744223

Conditions
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Bone Marrow Diseases, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • University Hospitals of Cleveland Cleveland, Ohio, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Active, not recruiting

Study of Gene Modified Donor T Cell Infusion in Patients With Recurrent Disease After Allogeneic Transplant

NCT02477878

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +22 more
Locations
  • BMT Program at Northside Hospital Atlanta, Georgia, United States
  • University of Kansas Westwood, Kansas, United States
  • Roswell Park Buffalo, New York, United States
  • Oregon Health & Science University Portland, Oregon, United States
View Trial Details
Active, not recruiting

An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia

NCT04053803

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Foundation for Sickle Cell Disease Research Hollywood, Florida, United States
  • Baylor Scott & White Medical Center - Temple Temple, Texas, United States
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
View Trial Details
Active, not recruiting

Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes

NCT02912208

Conditions
Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +4 more
Locations
  • CHU Amiens Amiens, France
  • Centre d'Avignon Avignon, France
  • Hôpital de la Côte Basque Bayonne, France
  • Centre d'Avicenne, Hôpital d'Avicenne Bobigny, France
View all 64 locations
View Trial Details

Related conditions